Letairis® (ambrisentan) logo
For HCPs

Letairis (ambrisentan) is a prescription medicine used to treat pulmonary arterial hypertension (PAH), which is high blood pressure in the arteries of the lungs.

RegistrationJoin our
PAH
community.
Sign up now.

Designed for patients taking Letairis, More to My Story provides education and support about topics that may interest you, including:

  • Important information about starting Letairis and staying on track with your treatment
  • Recipes
  • Exercise tips
  • Empowering patient stories
  • And more topics
  • Recipes
  • Exercise tips
  • Empowering patient stories
  • And more topics

Please complete the form below to get started.

An asterisk (*) indicates a required field.

*Select the phrase that best describes you:
Please select a phrase.
*Contact information
*Approximately when did you start taking Letairis?

Privacy for your personal information

By providing your name, address, email address, and other information and clicking "Complete my registration," you agree to receive periodic educational updates about Gilead products or services. Gilead respects the privacy of your personal information. Gilead will only use the information that you provide to send you marketing or informational materials; analyze and use your information to improve or develop products, services, and programs; and contact you about marketing programs or research and health topics that may be of interest to you. Gilead will not sell or rent your personally identifiable information. For more information regarding our privacy policy, please read Gilead's privacy policy. You may opt out of this program at any time by clicking the "Unsubscribe" link in any email by calling 1-800-GILEAD5 or 1-650-522-5775, by emailing privacy@gilead.com, or by sending a letter to Gilead Sciences, Inc., Attention: Privacy, 333 Lakeside Drive, Foster City, CA 94404.

TAP FOR IMPORTANT SAFETY INFORMATION INCLUDING AN IMPORTANT WARNING ON SERIOUS BIRTH DEFECTS IF TAKEN DURING PREGNANCY.
TAP FOR IMPORTANT SAFETY INFORMATION INCLUDING AN IMPORTANT WARNING ON SERIOUS BIRTH DEFECTS IF TAKEN DURING PREGNANCY.